Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-06-14 Clayman Michael D. Director Grant or award · Stock Option (Right to buy) +12,500 12,500
2017-06-15 Clayman Michael D. Director Grant or award · Stock Option (Right to buy) +12,500 12,500
2016-06-16 Clayman Michael D. Director Grant or award · Stock Option (Right to buy) +12,500 12,500
2015-06-10 Clayman Michael D. Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2015-06-10 Clayman Michael D. Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2014-07-28 Clayman Michael D. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000

Page 1 of 1 · 6 trades